Cargando…

Antifungal Prophylaxis with Posaconazole versus Fluconazole in Children with Neutropenia Following Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

BACKGROUND: Invasive fungal diseases (IFDs) are common and contribute to mortality in patients undergoing hematopoietic stem cell transplantation (HSCT). The relative efficacies of posaconazole (POS) and fluconazole (FLU) as primary antifungal prophylaxes are uncertain. METHODS: A retrospective stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takpradit, Chayamon, Wangkittikal, Chonthida, Rungmaitree, Supattra, Buaboonnam, Jassada, Narkbunnam, Nattee, Phuakpet, Kamon, Vathana, Nassawee, Sanpakit, Kleebsabai, Pongtanakul, Bunchoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331121/ https://www.ncbi.nlm.nih.gov/pubmed/34354383 http://dx.doi.org/10.2147/JBM.S319890

Ejemplares similares

Outcomes of Overt and Non-overt Disseminated Intravascular Coagulation Using the ISTH DIC Scoring System in Children: A Single-Center Study
por: Buaboonnam, Jassada, et al.
Publicado: (2023)

Long-Term Effectiveness, Safety, and Tolerability of Twice-Daily Dosing with Deferasirox in Children with Transfusion-Dependent Thalassemias Unresponsive to Standard Once-Daily Dosing
por: Buaboonnam, Jassada, et al.
Publicado: (2021)

Invasive Fungal Diseases in Children with Acute Leukemia and Severe Aplastic Anemia
por: Supatharawanich, Sutatta, et al.
Publicado: (2021)

Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia
por: Döring, M., et al.
Publicado: (2015)

Hemoglobin H Disease and Growth: A Comparative Study of DHbH and NDHbH Patients
por: Hunnuan, Issanun, et al.
Publicado: (2023)

GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction
por: Sujjitjoon, Jatuporn, et al.
Publicado: (2020)

ITPA Polymorphisms and the Incidence of Toxicities in Children with Acute Lymphoblastic Leukemia
por: Svasdisant, Patpetra, et al.
Publicado: (2023)

Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in Thailand
por: Suwannaying, Kunanya, et al.
Publicado: (2022)

Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study
por: Rujkijyanont, Piya, et al.
Publicado: (2019)

Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia
por: Yu, Donghui T, et al.
Publicado: (2006)

Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands
por: Jansen, Jeroen P., et al.
Publicado: (2010)

Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
por: Chen, Chiung-Kuang, et al.
Publicado: (2010)

Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology–oncology patients: a retrospective cohort study
por: Kung, Hsiang-Chi, et al.
Publicado: (2014)

A Rare Case of Blastic Plasmacytoid Dendritic Cell Neoplasm in a Child Mimicking Lymphoma/Leukemia Cutis
por: Phusuphitchayanan, Phanitchanat, et al.
Publicado: (2022)

Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain
por: Grau, Santiago, et al.
Publicado: (2012)

Safety, Tolerability, and Pharmacokinetics (PK) of Posaconazole (POS) Intravenous (IV) Solution and Oral Powder for Suspension in Children With Neutropenia
por: Groll, Andreas H, et al.
Publicado: (2017)

A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia
por: Arrieta, Antonio C., et al.
Publicado: (2019)

Posaconazole for lobomycosis
por: Pasqualotto, Alessandro C., et al.
Publicado: (2021)

1558. A Population Pharmacokinetic Model for Posaconazole Intravenous Solution and Oral Powder for Suspension Formulations in Pediatric Patients With Neutropenia
por: Winchell, Gregory A, et al.
Publicado: (2019)

Practices and challenges for hemophilia management under resource constraints in Thailand
por: Moonla, Chatphatai, et al.
Publicado: (2023)

Exposure of Cryptococcus neoformans to Seven Commonly Used Agricultural Azole Fungicides Induces Resistance to Fluconazole as Well as Cross-Resistance to Voriconazole, Posaconazole, Itraconazole and Isavuconazole
por: Drakulovski, Pascal, et al.
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics of Posaconazole
por: Chen, Lu, et al.
Publicado: (2020)

Posaconazole and isavuconazole induced hypomagnesaemia
por: Burston, John, et al.
Publicado: (2018)

Role of posaconazole in the treatment of oropharyngeal candidiasis
por: Ianas, Voichita, et al.
Publicado: (2010)

Therapeutic Drug Monitoring of Posaconazole: an Update
por: Dekkers, Bart G. J., et al.
Publicado: (2016)

Mineralocorticoid hypertension and hypokalaemia induced by posaconazole
por: Boughton, Charlotte, et al.
Publicado: (2018)

Posaconazole: An Update of Its Clinical Use
por: Leung, Simon, et al.
Publicado: (2015)

Comparison of clinical pharmacology of voriconazole and posaconazole
por: Sienkiewicz, Beata M., et al.
Publicado: (2016)

Posaconazole-Induced Apparent Mineralocorticoid Excess
por: Pandit, Amar, et al.
Publicado: (2020)

Posaconazole treatment of refractory coccidioidomycosis in dogs
por: Shubitz, Lisa F., et al.
Publicado: (2021)

Posaconazole: Lack of efficacy: case report
Publicado: (2022)

Posaconazole as rescue therapy in African histoplasmosis
por: Gonçalves, Daniel, et al.
Publicado: (2013)

Formation and Characterisation of Posaconazole Hydrate Form
por: Lykouras, Michail, et al.
Publicado: (2022)

Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations
por: Märtson, Anne‐Grete, et al.
Publicado: (2019)

Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation
por: Belling, Morgan, et al.
Publicado: (2017)

Fluconazole (Diflucan®)
por: Hollier, Lisa M., et al.
Publicado: (1995)

Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes
por: Dahlén, Torsten, et al.
Publicado: (2015)

Fluconazole Resistance and Virulence in In Vitro Induced-Fluconazole Resistant Strains and in Clinical Fluconazole Resistant Strain of Cryptococcus deuterogattii
por: Bertout, Sébastien, et al.
Publicado: (2023)

Outcomes of Single-Dose Empirical Antibiotic Treatment in Children With Suspected Sepsis Implemented in the Emergency Department
por: Khanthathasiri, Suwimon, et al.
Publicado: (2022)

Role of posaconazole in the management of oropharyngeal and esophageal candidiasis
por: Vazquez, Jose A
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_nqvcf3meinc6m6ubngktuml7tm